BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totaling 633 shares, a decline of 81.8% from the April 30th total of 3,486 shares. Based on an average daily trading volume, of 48,182 shares, the short-interest ratio is presently 0.0 days.
BioPharma Credit Price Performance
Shares of BioPharma Credit stock opened at $0.96 on Thursday. BioPharma Credit has a one year low of $0.83 and a one year high of $1.02. The business has a 50-day simple moving average of $0.94 and a 200 day simple moving average of $0.90.
BioPharma Credit Company Profile
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Recommended Stories
- Five stocks we like better than BioPharma Credit
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
